Brief Title
Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project
Official Title
Gynecological Cancer Survivors' Views on Follow-up After Cancer Treatment
Brief Summary
Follow-up of cancer patients accounts for a substantial part of outpatient activity, and
alternative models of care are developing. In some countries, low-risk follow-up is already
done in primary care, mainly in breast, and colorectal cancer. In this study the
investigators will explore gynecological cancer patients about their expectations regarding
their future follow-up plan. Further, the investigators will ask about the experience and
satisfaction among patients who have already attended a follow-up programme for 2-3 years. In
addition, the investigators will especially focus on the cooperation aspect between primary
and secondary care. The investigators hypothesize that follow-up of selected gynecological
cancer patients can be done by general practitioners.
Detailed Description
After gynaecological cancer patients have completed their treatment, they are followed up at
a gynaecological outpatient clinic for a number of years. The aim of such follow-up is to
detect recurrence, improve survival and reduce adverse effects of the treatment. The national
guide for oncological gynaecology recommends follow-up by a specialist for five years at
intervals depending on cancer type. Several review studies on follow-up of endometrial,
cervical and ovarian cancer patients show large international variations in follow-up
routines. There are only retrospective studies available, and they indicate that most
recurrences are discovered within the first three years after completed treatment, and, in
most cases, by the women themselves. More intensive surveillance does not appear to affect
the time for discovery of recurrence.
A few randomised controlled studies and retrospective cohort studies have been published that
focus on follow-up of colon cancer and breast cancer patients by general practitioners versus
by hospital specialists. These studies have not shown any significant differences between the
groups in terms of detection of recurrence, incidence of serious clinical events connected
with recurrence or health-related quality of life.
The investigators therefore plan to perform a study in which both gynaecological cancer
patients and their regular general practitioners are asked about their views on patient
follow-up after completed treatment. The investigators especially wish to focus on the
collaboration aspect.
Study Type
Observational
Primary Outcome
Patient expectation questionnaire
Secondary Outcome
Patient satisfaction questionnaire
Condition
Endometrial Cancer
Study Arms / Comparison Groups
recently treated patients
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
239
Start Date
September 2012
Completion Date
December 2015
Primary Completion Date
December 2015
Eligibility Criteria
Inclusion Criteria:
- > 18 years
- histologically or cytologically proven cancer
Exclusion Criteria:
- Unability to fill out questionnaires (due to language or cognitive barriers)
Gender
Female
Ages
19 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Mette Brekke, PhD, ,
Location Countries
Norway
Location Countries
Norway
Administrative Informations
NCT ID
NCT01691144
Organization ID
2012/355B
Responsible Party
Principal Investigator
Study Sponsor
University of Oslo
Study Sponsor
Mette Brekke, PhD, Study Chair, University of Oslo
Verification Date
May 2016